Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2000
06/29/2000CA2356736A1 Use of etherlysophospholipids as antiinflammatory agents
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2356174A1 Kidney disease detection and treatment
06/29/2000CA2356162A1 Substituted tricyclics
06/29/2000CA2356159A1 Novel spla2 inhibitors
06/29/2000CA2356010A1 Treatment of hepatitis c virus infections with interleukin-10
06/29/2000CA2355902A1 Sulfonamide hydroxamates
06/29/2000CA2355874A1 .alpha.v.beta.6 integrin inhibitors
06/29/2000CA2355861A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
06/29/2000CA2355627A1 Foaming antacid suspension tablets
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2355074A1 Lymphocytic membrane proteins
06/29/2000CA2352309A1 Oral vaccine against diarrhea
06/28/2000EP1013639A1 Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit
06/28/2000EP1012321A2 Viral infection of cells using viral vectors
06/28/2000EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
06/28/2000EP1012292A1 Ntn-2 member of tnf ligand family
06/28/2000EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them
06/28/2000EP1012242A1 Human sigma receptor
06/28/2000EP1012186A2 Keratinocyte growth factors and uses thereof
06/28/2000EP1012171A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
06/28/2000EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011721A1 Vaginal lactobacillus medicant
06/28/2000EP1011714A2 Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
06/28/2000EP1011709A1 Inhibition of apoptotis using prosaposin receptor agonists
06/28/2000EP1011693A1 Use of locally delivered metal ions for treatment of periodontal disease
06/28/2000EP1011677A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
06/28/2000EP1011675A1 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea
06/28/2000EP1011674A1 Transdermal therapeutic system containing the active substance scopolamine base
06/28/2000EP1011664A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
06/28/2000EP1011663A1 BETA-LACTAM INHIBITORS OF CoA-IT
06/28/2000EP1011631A1 Antacid composition
06/28/2000EP0706394A4 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
06/28/2000CN1258295A Novel form of S-omeprazole
06/28/2000CN1258293A Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF 'alpha' levels
06/28/2000CN1258290A Salt
06/28/2000CN1258219A Benzocycloheptathiophene compounds
06/28/2000CN1258218A Mixture of primary fatty acids obtained from sugar can wax and pharmaceutical use thereof
06/28/2000CN1258217A Pharmaceutical formulation of omeprazole
06/28/2000CN1257916A Ginseng-tortoise wine and its preparing process
06/28/2000CN1257735A Medicine for treating constipation and its preparing process
06/28/2000CN1257732A Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease
06/28/2000CN1257728A Medical capsule for building up body and invigorating function of kidney
06/28/2000CN1257723A Medicine for dissolving and discharging calculi by omphalotherapy
06/28/2000CN1257709A Chinese medicine
06/28/2000CN1053832C Chinese patent drug for cirrhosis of liver
06/28/2000CN1053827C Oral administration paste for curing senile constipation
06/28/2000CN1053825C 'Wuling' hepatitis C powder
06/27/2000US6080841 Human induced tumor protein
06/27/2000US6080774 Substituted biphenylsulfonamide endothelin antagonists
06/27/2000US6080766 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
06/27/2000US6080764 Superoxide radical inhibitor
06/27/2000US6080757 Treatment of helicobacter (campylobacter) pylori infections; treatment and prevention of peptic ulcers, gastritis, dyspepsia, and gastric cancer
06/27/2000US6080740 Spiro-ketal derivatives and their use as therapeutic agents
06/27/2000US6080422 Administering a lipid acceptor selected from the group consisting of large liposomes comprised of phospholipids substantially free of sterol and small acceptors. prevention of restenosis during revascularization
06/27/2000US6080403 Protease containing hairball remedy and use thereof
06/27/2000US6080402 Immobilization of lipases by entrapment in silica matrices
06/27/2000CA2198564C Method of reducing tissue damage associated with non-cardiac ischemia
06/27/2000CA2131021C Use of injectable biomaterials for the repair and augmentation of the anal sphincters
06/22/2000WO2000036105A1 Prostacyclin-stimulating factor-2
06/22/2000WO2000036104A1 Pancreatic polypeptide zsig66
06/22/2000WO2000036091A2 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035937A1 47 human secreted proteins
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035919A2 Quinoline derivatives
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035910A1 Derivative of paroxetine
06/22/2000WO2000035855A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000WO2000035465A2 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
06/22/2000WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035448A1 New pharmaceutical formulation
06/22/2000WO2000035444A1 USE OF η-TOCOPHEROL AND ITS OXIDATIVE METABOLITE LLU-α IN THE TREATMENT OF DISEASE
06/22/2000WO2000035443A1 Method and composition for the maintenance and restitution of gut integrity
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035434A2 Compositions and methods for the treatment of anorectal disorders
06/22/2000WO2000035430A2 Homer a new target of treating psychiatric disorders
06/22/2000WO2000035428A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000WO2000035408A2 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
06/22/2000WO2000035303A1 Fibre blend for enteral composition
06/22/2000WO2000035280A1 Exo-r-mecamylamine formulation and use in treatment
06/22/2000WO2000035279A1 Exo-s-mecamylamine formulation and use in treatment
06/22/2000WO2000024388A3 Combination of 5-aminosalicylic acid and a budesonide, 6-methyl prednisolone or prednisolone for treating inflammatory disorders of the intestinal tract
06/22/2000WO2000011029A3 Novel anti-diabetic peptides
06/22/2000WO2000008948A3 Carbohydrate mixture
06/22/2000WO1999038504A8 Pharmaceutical uses of optically pure (-)-bupropion
06/22/2000CA2393442A1 Exo-r-mecamylamine formulation and use in treatment
06/22/2000CA2362423A1 47 human secreted proteins
06/22/2000CA2355971A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355363A1 Prostacyclin-stimulating factor-2
06/22/2000CA2355234A1 Quinoline derivatives
06/22/2000CA2355039A1 Pancreatic polypeptide zsig66
06/22/2000CA2354875A1 Piperazine derivatives
06/22/2000CA2354543A1 Compositions and methods for the treatment of anorectal disorders
06/22/2000CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354323A1 Homer a new target of treating psychiatric disorders
06/22/2000CA2352613A1 New pharmaceutical formulation
1 ... 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 ... 1258